Role of Retinoids, Rexinoids and Thyroid Hormone in the Expression of Cytochrome P450 Enzymes

被引:46
作者
Brtko, Julius [1 ]
Dvorak, Zdenek [2 ]
机构
[1] Slovak Acad Sci, Inst Expt Endocrinol, SK-83306 Bratislava, Slovakia
[2] Palacky Univ, Dept Cell Biol & Genet, Fac Sci, Olomouc 78371, Czech Republic
关键词
Cytochrome P450; hormonal regulation; nuclear receptors; thyroid hormone; retinoids; ARYL-HYDROCARBON-RECEPTOR; PREGNANE-X-RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; CYP3A4; GENE-EXPRESSION; VITAMIN-D-RECEPTOR; DRUG-METABOLIZING-ENZYMES; N-TERMINAL KINASE; HEPATOCYTE NUCLEAR FACTOR-4-ALPHA; MICROTUBULES-INTERFERING AGENTS; MECHANISM-BASED INHIBITION;
D O I
10.2174/138920011795016881
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Retinoic acid receptors (RARs), retinoid X receptors (RXRs) and thyroid hormone receptors (TRs) are nuclear receptors that are crucial transcriptional regulators of many cellular processes such as differentiation, development, apoptosis, carbohydrate and lipid metabolism, homeostasis etc. In addition, RXRs are common heterodimerization partners for several receptors including vitamin D receptor, pregnane X receptor (PXR), constitutive androstane receptor (CAR) etc. In the course of 90s', PXR and CAR were discovered as key xenosensors regulating drug-metabolizing enzymes. Since there exist various cross-talks between cell signaling pathways, this was not surprising that RXRs, RARs and TRs were identified as regulators of human drug-metabolizing cytochromes P450 and cytochromes P450 involved in metabolism of endogenous compounds. Hence, a link between regulation of xenobiotic metabolizing enzymes and regulatory pathways of intermediary metabolism was established. Additionally, several drug-metabolizing enzymes are involved in metabolism of retinoids, rexinoids and thyroid hormones. In the current paper, we summarize the knowledge on the role of RARs, RXRs and TRs in the regulation of drug metabolizing cytochromes P450, and vice versa on the role of P450s in homeostasis of retinoids, rexinoids and thyroid hormone.
引用
收藏
页码:71 / 88
页数:18
相关论文
共 350 条
[1]   Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine [J].
Adachi, J ;
Mori, Y ;
Matsui, S ;
Takigami, H ;
Fujino, J ;
Kitagawa, H ;
Miller, CA ;
Kato, T ;
Saeki, K ;
Matsuda, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (34) :31475-31478
[2]   Cytochrome P450 gene polymorphism and cancer [J].
Agúndez, JAG .
CURRENT DRUG METABOLISM, 2004, 5 (03) :211-224
[3]   CELLULAR AND MOLECULAR ASPECTS OF ADIPOSE-TISSUE DEVELOPMENT [J].
AILHAUD, G ;
GRIMALDI, P ;
NEGREL, R .
ANNUAL REVIEW OF NUTRITION, 1992, 12 :207-233
[4]   Regulation of drug-metabolizing enzymes and transporters in inflammation [J].
Aitken, AE ;
Richardson, TA ;
Morgan, ET .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2006, 46 :123-149
[5]   THE PHARMACOLOGY AND PHARMACOKINETICS OF THE RETINOIDS [J].
ALLEN, JG ;
BLOXHAM, DP .
PHARMACOLOGY & THERAPEUTICS, 1989, 40 (01) :1-27
[6]   Influence of food polyphenols on aryl hydrocarbon receptor-signaling pathway estimated by in vitro bioassay [J].
Amakura, Yoshiaki ;
Tsutsumi, Tomoaki ;
Sasaki, Kumiko ;
Nakamura, Masafumi ;
Yoshida, Takashi ;
Maitani, Tamio .
PHYTOCHEMISTRY, 2008, 69 (18) :3117-3130
[7]   Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes [J].
Andrieux, L ;
Langouet, S ;
Fautrel, A ;
Ezan, F ;
Krauser, JA ;
Savouret, JF ;
Guengerich, FP ;
Baffet, G ;
Guillouzo, A .
MOLECULAR PHARMACOLOGY, 2004, 65 (04) :934-943
[8]   Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status [J].
Angus, WGR ;
Larsen, MC ;
Jefcoate, CR .
CARCINOGENESIS, 1999, 20 (06) :947-955
[9]   Nuclear hormone receptors and gene expression [J].
Aranda, A ;
Pascual, A .
PHYSIOLOGICAL REVIEWS, 2001, 81 (03) :1269-1304
[10]   An update on the dietary ligands of the AhR [J].
Ashida, Hitoshi ;
Nishiumi, Shin ;
Fukuda, Itsuko .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (11) :1429-1447